We are live on ! Find out more
MHR

Matthew Hamilton Rosenberg Portfolio holdings

AUM $537M
1-Year Est. Return 18.21%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+18.21%
3 Year Est. Return
+48.25%
5 Year Est. Return
+48.63%
10 Year Est. Return
AUM
$537M
AUM Growth
+$48.7M
Cap. Flow
+$11.4M
Cap. Flow %
2.12%
Top 10 Hldgs %
57.54%
Holding
818
New
19
Increased
183
Reduced
114
Closed
26
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDA icon
776
Idacorp
IDA
$7.99B
$454 ﹤0.01%
3
BMBL icon
777
Bumble
BMBL
$385M
$445 ﹤0.01%
139
RELX icon
778
RELX
RELX
$60.4B
$412 ﹤0.01%
13
SKT icon
779
Tanger
SKT
$4.27B
$355 ﹤0.01%
9
AIT icon
780
Applied Industrial Technologies
AIT
$12B
$338 ﹤0.01%
1
CNH
781
CNH Industrial
CNH
$21.9B
$326 ﹤0.01%
29
NSSC icon
782
Napco Security Technologies
NSSC
$1.32B
$266 ﹤0.01%
7
IXG icon
783
iShares Global Financials ETF
IXG
$700M
$249 ﹤0.01%
2
CBOE icon
784
Cboe Global Markets
CBOE
$30.6B
$243 ﹤0.01%
1
OGN icon
785
Organon & Co
OGN
$3.62B
$229 ﹤0.01%
+17
New +$203
SPLV icon
786
Invesco S&P 500 Low Volatility ETF
SPLV
$7.12B
$225 ﹤0.01%
3
VYX icon
787
NCR Voyix
VYX
$1.17B
$204 ﹤0.01%
25
REZI icon
788
Resideo Technologies
REZI
$3.01B
$156 ﹤0.01%
5
COMT icon
789
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.35B
$121 ﹤0.01%
4
CHRD icon
790
Chord Energy
CHRD
$8.09B
$114 ﹤0.01%
1
FIS icon
791
Fidelity National Information Services
FIS
$20.4B
$78 ﹤0.01%
2
ASIX icon
792
AdvanSix
ASIX
$462M
$20 ﹤0.01%
1
ALNY icon
793
Alnylam Pharmaceuticals
ALNY
$35B
-3
Closed -$993
AMLP icon
794
Alerian MLP ETF
AMLP
$13.6B
-171
Closed -$9K
AMP icon
795
Ameriprise Financial
AMP
$49.4B
-3
Closed -$1.33K
APP icon
796
Applovin
APP
$104B
-2
Closed -$796
ARGX icon
797
argenx
ARGX
$63.2B
-3
Closed -$2.19K
AVY icon
798
Avery Dennison
AVY
$13B
-52
Closed -$8.98K
BR icon
799
Broadridge
BR
$19.3B
-6
Closed -$975
BRBR icon
800
BellRing Brands
BRBR
$1.15B
-54
Closed -$869

Similar funds

Matthew Hamilton Rosenberg's Q2 2026 Portfolio in Review

As of Q2 2026, Matthew Hamilton Rosenberg held 818 positions worth $537M, up 10% from $488M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Matthew Hamilton Rosenberg's Q2 2026 filing shows 19 new, 183 increased, 114 reduced and 26 closed positions. Its largest new stake was AstraZeneca: 2,051 shares worth $389K. The largest sale was Vanguard Intermediate-Term Bond ETF, an estimated $2.52M.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Financials.

  • Matthew Hamilton Rosenberg's largest Q2 2026 buy was AstraZeneca: 2,051 shares worth $389K.
  • Matthew Hamilton Rosenberg added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2026, an estimated $4.06M increase.
  • Matthew Hamilton Rosenberg's biggest Q2 2026 reduction was Vanguard Intermediate-Term Bond ETF, cutting an estimated $2.52M.
  • Matthew Hamilton Rosenberg fully exited Vanguard Short Duration Tax-Exempt Bond ETF in Q2 2026, selling an estimated $244K.
  • Matthew Hamilton Rosenberg's ten largest holdings make up 58% of its $537M portfolio in Q2 2026.
  • Matthew Hamilton Rosenberg opened 19 new positions and closed 26 in Q2 2026.
  • Matthew Hamilton Rosenberg's portfolio value rose 10% quarter-over-quarter to $537M.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.